Clinical trial

Efficacy of Dalfampridine on Upper Extremity Function in Patients With MS

NCT02259361

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2014-11-01

PhasePHASE4

Study timeline

Study start (unknown)2014-11-01Date precision: month

Registry last updated2014-10-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

Sustained-release oral dalfampridineDRUG

PlaceboDRUG

Sponsors & collaborators

Sheba Medical Centerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02259361 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.